Related Experiment Videos
Vesicular systems in ocular drug delivery: an overview
Indu P Kaur1, Alka Garg, Anil K Singla
1University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160 014, India. indupalkaur@yahoo.com
International Journal of Pharmaceutics
|December 31, 2003
Summary
Conventional ocular drug delivery faces challenges like poor bioavailability due to tear turnover and short residence time. Novel vesicular drug delivery systems offer improved ocular bioavailability, overcoming limitations of traditional ophthalmic formulations.
Area of Science:
- Ophthalmology
- Pharmaceutics
- Drug Delivery
Background:
- Achieving effective drug concentration at the ocular site is crucial for pharmacotherapeutics.
- Conventional ocular dosage forms (solutions, suspensions, ointments) exhibit poor drug bioavailability.
- Factors like tear turnover, poor absorption, and corneal impermeability limit topical ocular drug efficacy.
Purpose of the Study:
- To review the limitations of conventional ocular therapy.
- To explore novel approaches for enhancing ocular drug bioavailability.
- To evaluate the advantages of vesicular drug delivery systems for ocular applications.
Main Methods:
- Literature review of conventional and novel ocular drug delivery systems.
- Analysis of factors affecting ocular drug bioavailability.
- Comparative assessment of vesicular systems against traditional formulations.
Main Results:
- Conventional ophthalmic formulations are insufficient for treating various ocular diseases.
- Novel approaches, particularly vesicular systems, show promise in improving ocular drug bioavailability.
- Vesicular systems offer advantages over conventional methods in terms of drug residence time and absorption.
Conclusions:
- Traditional ocular drug delivery methods have significant limitations.
- Vesicular drug delivery systems represent a promising strategy to enhance ocular bioavailability.
- Further research is needed to optimize vesicular systems for effective ocular therapy and overcome future challenges.